Pfizer's Champix patents in India is already opposed by Dr Reddy's
Pfizer's high profile anti-smoking drug Champix is facing patent uncertainty in India as Dr Reddy's has filed a post grant opposition against selling the drug in India.
You can subscribe by email to receive newsletter updates:
Subscribe through a RSS feed reader
News Feed Comments Feed